IDEXX Laboratories, Inc. vs United Microelectronics Corp — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while United Microelectronics Corp trades at $22.96 (market cap $58.02B). The key difference: United Microelectronics Corp is the larger of the two by market cap, and United Microelectronics Corp pays a 1.76% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and United Microelectronics Corp for 42 Days on average.
| IDXX | UMC | |
|---|---|---|
Market Cap | $40.43B | $58.02B |
Volume | 692,164 | 11,897,809 |
Sector | Health | Technology |
52-Week High | $766.68 | $28.02 |
52-Week Low | $504.70 | $7.02 |
Typical Hold Time | 46 Days | 42 Days |
Enterprise Value | $41.32B | $55.10B |
Dividend Yield | — | 1.76% |
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
UMC trades at $22.82, down 2.1% today but maintains strong fundamental momentum with three consecutive quarterly earnings beats. The stock shows bullish technical signals despite mixed moving averages, while fundamentals reveal robust profitability with 32.75% net income margin and improving cash flow trends. Recent news highlights analyst upgrades and strong AI-driven growth prospects.
Outlook remains positive with projected revenue growth to $250.7B in 2026 and intrinsic value estimates around $29 suggesting upside potential. Key risks include semiconductor cycle volatility and competitive pressures from larger foundries. Analyst consensus leans Hold but recent Strong Buy upgrades indicate growing optimism.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →